חוב כולל להון Anixa Biosciences Inc (ANIX)

Anixa Biosciences, Inc. (ANIX) integrates ESG principles into the development of anti-cancer vaccines, ensuring manufacturing sterility and ethical testing. A flawless corporate image is bolstered by a partnership with the Cleveland Clinic, fostering trust among physicians. This price chart on GURU.Markets reflects a market trend for the asset with a debt-to-equity ratio of 0.01, confirming its status as an innovative brand in the diagnostics of female neoplasms.

Total debt-to-equity measures a business's reliance on external borrowings relative to its own resources. This metric is calculated as the sum of all liabilities divided by the net asset value, reflecting financial stability. By analyzing the ratio of total financial debt to equity, an investor determines the balance between credit leverage and solvency. A downward trend confirms deleveraging. For Anixa Biosciences, Inc. (ANIX), such stability is critical for the development of AI diagnostics and cancer vaccines.